KalVista Pharmaceuticals (KALV) Revenue (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 418.18% |
| Apr 30, 2020 | 142.49% |
| Jan 31, 2020 | -59.77% |
| Oct 31, 2019 | 16.36% |
| Jul 31, 2019 | 15.14% |
| Apr 30, 2019 | -24.78% |
| Jan 31, 2019 | -30.44% |
| Oct 31, 2018 | 50.40% |
| Jul 31, 2018 | -23.18% |
| Apr 30, 2018 | 107.64% |
| Jan 31, 2018 | 106.83% |
| Oct 31, 2017 | 1,073.96% |
| Jul 31, 2017 | -15.79% |
| Apr 30, 2017 | -54.03% |
| Jan 31, 2017 | 25.89% |
| Oct 31, 2016 | -79.79% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | -12.50% |
| Dec 31, 2014 | -20.00% |
| Sep 30, 2014 | 100.00% |
| Jun 30, 2014 | -16.67% |